Clinical Trials · NCT01611571
Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Columbia University
- Enrollment
- 31
- Start date
- Dec 2003
- Locations
- 1 site, United States
- Primary endpoint
- Change in Spine Bone Density